HD..
I do not want anyone thinking I'm blowing smoke up their oseaux regarding the scripts. I do see a real role for revenue in this predicament. At 20,000 a week, they would be home free. It would a self sustaining revenue stream which is the holy grail for biotechs.
I also see the whole idea of inflammation being the bad guy coming to the forefront. First we have Dr Sears and now Dr. Oz talking up omega-6s as the problem and EPA as the solution. Lay people seem to understand the dosage of "fish oil" is simply too low to be effective. For some reason the statin supported MDs do not seem to understand that. The internet is powerful.
I still have my shares. Amarin is rapidly approaching the legal limit of the number of mud pies that can be thrown at a biotech..We are way over due for some good news. Everyone can help, get out there and talk up Vascepa.
":>) JL
Market Data 
Markets 
AI
